A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Public ClinicalTrials.gov record NCT01582503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Dosing Regimens of MEMP1972A in Adults With Allergic Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids and a Second Controller (COSTA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of 3 dosing regimens of MEMP1972A in patients with allergic asthma who remain inadequately controlled on chronic therapy with high dose inhaled corticosteroids and a second controller medication.Patients will be randomized to 4 Arms to receive subcutaneous repeating dose of either MEMP1972A 150 mg, 300 mg, or 450 mg, or placebo. Patients will continue their usual asthma medication throughout the study. Anticipated time on study treatment is 36 weeks, with a 48-week follow-up.
Study identification
- NCT ID
- NCT01582503
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 578 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2012 (Type not available)
- Primary completion
- May 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- Nov 2, 2016
2012 – 2014
United States locations
- U.S. sites
- 51
- U.S. states
- 28
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Bakersfield | California | 93301 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Long Beach | California | 90808 | — |
| Not listed | Mission Viejo | California | 92691 | — |
| Not listed | Rancho Cordova | California | 95762 | — |
| Not listed | Redwood City | California | 94063 | — |
| Not listed | Stockton | California | 95207 | — |
| Not listed | Torrance | California | 90505 | — |
| Not listed | Upland | California | 91786 | — |
| Not listed | Centennial | Colorado | 80112 | — |
| Not listed | Denver | Colorado | 80206 | — |
| Not listed | New Haven | Connecticut | 06510 | — |
| Not listed | Tampa | Florida | 33613 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Albany | Georgia | 31707 | — |
| Not listed | Twin Falls | Idaho | 83301 | — |
| Not listed | Normal | Illinois | 61761 | — |
| Not listed | River Forest | Illinois | 60305 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Overland Park | Kansas | 66210 | — |
| Not listed | Louisville | Kentucky | 40223 | — |
| Not listed | Baltimore | Maryland | 21236 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Bellevue | Nebraska | 68123 | — |
| Not listed | Omaha | Nebraska | 68130 | — |
| Not listed | Edison | New Jersey | 08820 | — |
| Not listed | Teaneck | New Jersey | 07666 | — |
| Not listed | The Bronx | New York | 10461 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Centerville | Ohio | 45458 | — |
| Not listed | Cincinnati | Ohio | 45231 | — |
| Not listed | Oklahoma City | Oklahoma | 73120 | — |
| Not listed | Tulsa | Oklahoma | 74136 | — |
| Not listed | Medford | Oregon | 97504 | — |
| Not listed | Philadelphia | Pennsylvania | 19140 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Providence | Rhode Island | 02906 | — |
| Not listed | Warwick | Rhode Island | 02865 | — |
| Not listed | Charleston | South Carolina | 29407 | — |
| Not listed | El Paso | Texas | 79903 | — |
| Not listed | El Paso | Texas | 79925 | — |
| Not listed | San Antonio | Texas | 78224 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Waco | Texas | 76712 | — |
| Not listed | Murray | Utah | 84107 | — |
| Not listed | Fairfax | Virginia | 22030 | — |
| Not listed | Spokane | Washington | 99204 | — |
| Not listed | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01582503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2016 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01582503 live on ClinicalTrials.gov.